SCHEMBL1480708

SCHEMBL1480708

[CH]1C[CH]NC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9346 0.67
SCHEMBL8329753 0.65
SCHEMBL235816 0.65
SCHEMBL525731 0.58
SCHEMBL15062540 0.58
SCHEMBL61422 0.52
SCHEMBL2088 0.50
SCHEMBL570870 0.49
SCHEMBL3279831 0.49
SCHEMBL515026 0.49

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 138 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210107912-A1 INHIBITORS OF CYCLIN-DEPENDENT KINASE 7 (CDK7) SYROS PHARMACEUTICALS, INC. 2021-04-15 US claimed
EP-3489232-A2 INHIBITORS OF CYCLIN-DEPENDENT KINASE 7 (CDK7) Syros Pharmaceuticals, Inc. (US) 2019-05-29 EP claimed
US-20170174692-A1 INHIBITORS OF CYCLIN-DEPENDENT KINASE 7 (CDK7) OXFORD FINANCE LLC, AS COLLATERAL AGENT 2017-06-22 US claimed
EP-3129371-A1 INHIBITORS OF CYCLIN-DEPENDENT KINASE 7 (CDK7) Syros Pharmaceuticals, Inc. (US) 2017-02-15 EP claimed
EP-3126352-A2 INHIBITORS OF CYCLIN-DEPENDENT KINASE 7 (CDK7) Syros Pharmaceuticals, Inc. (US) 2017-02-08 EP claimed
WO-2015154039-A2 INHIBITORS OF CYCLIN-DEPENDENT KINASE 7 (CDK7) SYROS PHARMACEUTICALS, INC. (US) 2015-10-08 WO claimed
WO-2015154022-A1 INHIBITORS OF CYCLIN-DEPENDENT KINASE 7 (CDK7) SYROS PHARMACEUTICALS, INC. (US) 2015-10-08 WO claimed
US-20130116284-A1 LIPOIC ACID AND NITROXIDE DERIVATIVES AND USES THEREOF RADIKAL THERAPEUTICS INC. (US) 2013-05-09 US claimed
EP-2569307-A2 LIPOIC ACID AND NITROXIDE DERIVATIVES AND USES THEREOF Radikal Therapeutics Inc. (US) 2013-03-20 EP claimed
WO-2011141909-A2 LIPOIC ACID AND NITROXIDE DERIVATIVES AND USES THEREOF RADIKAL THERAPEUTICS INC. (US) 2011-11-17 WO claimed
EP-1194437-A1 DIPHOSPHINE LIGANDS FOR METAL COMPLEXES Solvias AG (CH) 2002-04-10 EP claimed
EP-0850241-B1 IRIDIUM-DIPHOSPHINE COMPLEXES AND PROCESS FOR THE HYDROGENATION OF IMINES NOVARTIS AG (CH) 2001-08-29 EP claimed
WO-2001004120-A1 METHOD FOR PRODUCING BY STEREOSPECIFIC HYDRATION TETRAHYDROPTERINS AND OPTICALLY PURE DERIVATIVES, IN PARTICULAR TETRAHYDROFOLIC ACID AND ITS OPTICALLY PURE DERIVATIVES EPROVA AG (CH) 2001-01-18 WO claimed
WO-2001004131-A1 DIPHOSPHINE LIGANDS FOR METAL COMPLEXES SOLVIAS AG (CH) 2001-01-18 WO claimed
US-6008393-A A DITERTIARY DIPHOSPHINE WHICH IS BONDED TO A C2 TO C4 CARBON CHAIN, AND FORMS A 5 TO 7 MEMBERED RING WITH IRIDIUM HALIDE AND CONTAINING OXYACID ANION SUCH AS CARBOXYLIC ACID, SULFONIC ACID AND PHOSPHORIC ACID NOVARTIS AG (CH) 1999-12-28 US claimed
EP-0850241-A1 IRIDIUM-DIPHOSPHINE COMPLEXES AND PROCESS FOR THE HYDROGENATION OF IMINES Novartis AG (CH) 1998-07-01 EP claimed
WO-1997005150-A1 IRIDIUM-DIPHOSPHINE COMPLEXES AND PROCESS FOR THE HYDROGENATION OF IMINES NOVARTIS AG (CH) 1997-02-13 WO claimed
EP-0419409-B1 Iridium complexes, process for their preparation and their use CIBA GEIGY AG (CH) 1995-11-02 EP claimed
US-5112999-A With diphosphines and diphosphinites, catalysts for hydrogenation of imines to secondary amines CIBA-GEIGY CORPORATION (US) 1992-05-12 US claimed
EP-0419409-A2 Iridium complexes, process for their preparation and their use CIBA-GEIGY AG (CH) 1991-03-27 EP claimed